General Info
Location: Semmelweisstr. 7
Country: Germany
Industries: Cardiovascular, renal and metabolic, Immunology, Neuroscience, Oncology
Investment Regions: EU
Investment Stages:
Website: http://www.morphosys.com/
angel-group
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Searches show MorphoSys AG is primarily a biopharmaceutical company and not an active venture investor. The last public investment-like activity found was acquisition-related/partnership news in 2024 (MorphoSys entered into a business combination/acquisition activity and has made earlier collaborations). No evidence of investments into startups within the past 12 months was found. The most recent notable transaction was in 2024 involving Novartis business combination announcement; therefore the last known investment-like activity is more than 12 months ago. Startup mentioned in sources: Tango Therapeutics (filings referencing MorphoSys personnel connections).
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Lara …
Senior Vice President, Head of Controlling
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of MorphoSys AG
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI